# Smoking Termination Opportunity for inPatients

> **NCT01141855** · PHASE2,PHASE3 · COMPLETED · sponsor: **The Queen Elizabeth Hospital** · enrollment: 392 (actual)

## Conditions studied

- Tobacco Use Disorder

## Interventions

- **DRUG:** Champix
- **BEHAVIORAL:** Counselling alone

## Key facts

- **NCT ID:** NCT01141855
- **Lead sponsor:** The Queen Elizabeth Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 392 (ACTUAL)
- **Last updated:** 2012-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01141855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01141855, "Smoking Termination Opportunity for inPatients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01141855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*